| |
| |
|
| Insider
Information: |
Stephenson Brian C |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
76,472 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,136,628 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
76,472 |
|
|
| Total
Value |
$2,136,628 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bridgebio Pharma, Inc. |
BBIO |
|
2024-05-16 |
76,472 |
2019-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-01-02 |
4 |
AS |
$32.57 |
$238,243 |
D/D |
(7,164) |
362,752 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-01-03 |
4 |
AS |
$31.94 |
$117,440 |
D/D |
(3,636) |
359,116 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-02-03 |
4 |
AS |
$34.90 |
$203,379 |
D/D |
(5,827) |
353,289 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-02-04 |
4 |
AS |
$34.52 |
$171,692 |
D/D |
(4,973) |
348,316 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remark |
• – – |
2020-03-02 |
4 |
AS |
$31.79 |
$348,541 |
D/D |
(10,800) |
337,516 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-04-01 |
4 |
AS |
$26.01 |
$191,610 |
D/D |
(7,200) |
330,316 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-05-01 |
4 |
AS |
$29.11 |
$210,474 |
D/D |
(7,200) |
323,116 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-05-04 |
4 |
AS |
$30.00 |
$44,827 |
D/D |
(1,494) |
321,622 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-05-05 |
4 |
AS |
$30.49 |
$173,959 |
D/D |
(5,706) |
315,916 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-06-01 |
4 |
AS |
$29.31 |
$211,401 |
D/D |
(7,200) |
308,716 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-06-03 |
4 |
AS |
$30.04 |
$48,072 |
D/D |
(1,600) |
307,116 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-06-08 |
4 |
AS |
$30.00 |
$60,002 |
D/D |
(2,000) |
305,116 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-07-01 |
4 |
AS |
$30.64 |
$334,053 |
D/D |
(10,800) |
294,316 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-08-03 |
4 |
AS |
$27.22 |
$127,092 |
D/D |
(4,661) |
289,655 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2020-08-04 |
4 |
AS |
$27.20 |
$69,196 |
D/D |
(2,539) |
287,116 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Secretary, Treasurer & CFO |
• – – |
2023-02-03 |
4 |
AS |
$11.01 |
$671,922 |
D/D |
(61,040) |
219,184 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Secretary, Treasurer & CFO |
• – – |
2023-02-17 |
4 |
AS |
$12.65 |
$225,066 |
D/D |
(17,717) |
219,529 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Secretary, Treasurer & CFO |
• – – |
2023-03-03 |
4 |
AS |
$10.96 |
$687,148 |
D/D |
(62,692) |
156,837 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Secretary, Treasurer & CFO |
• – – |
2023-04-05 |
4 |
AS |
$15.45 |
$857,697 |
D/D |
(55,500) |
101,337 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Secretary, Treasurer & CFO |
• – – |
2023-05-03 |
4 |
AS |
$14.18 |
$920,693 |
D/D |
(64,929) |
36,408 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Secretary, Treasurer & CFO |
• – – |
2023-05-17 |
4 |
AS |
$14.01 |
$342,168 |
D/D |
(24,424) |
36,408 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Secretary, Treasurer & CFO |
• – – |
2023-08-17 |
4 |
AS |
$28.59 |
$648,455 |
D/D |
(22,683) |
36,710 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Secretary, Treasurer & CFO |
• – – |
2023-11-17 |
4 |
AS |
$29.10 |
$660,059 |
D/D |
(22,685) |
36,710 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remark |
• – – |
2019-07-01 |
4 |
B |
$17.00 |
$943,500 |
D/D |
55,500 |
368,446 |
2.74 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• – – |
2021-02-17 |
4 |
B |
$62.50 |
$500,000 |
D/D |
8,000 |
300,043 |
2.74 |
% |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
